Cetacaine Anesthetic NDC 10223-0202

NDC codes

FDA NDC Directory

Product NDC (as listed)10223-0202Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10223-0202Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
10223-0202-2	10223020202	1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASSMarketed from Jan 1, 1960
10223-0202-6	10223020206	1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASSMarketed from Jan 1, 1960
10223-0202-7	10223020207	1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASSMarketed from Jan 1, 1960
10223-0202-8	10223020208	1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASSMarketed from Jan 1, 1960

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cetacaine Anesthetic
Generic name (nonproprietary): benzocaine, butamben, and tetracaine hydrochloride
Active ingredients: Benzocaine — .028 g/.2gButamben — .004 g/.2gTetracaine hydrochloride — .004 g/.2g
Dosage form: Solution
Route: Topical
Labeler: Cetylite Industries, Inc.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jan 1, 1960
Listing expires: Dec 31, 2026
Other FDA classes: Allergens (Chemical structure)Cell-mediated Immunity (Physiologic effect)Esters (Chemical structure)Increased Histamine Release (Physiologic effect)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 10223-0202_66344c64-2439-4a34-8eb4-707e707c8ab1SPL ID 66344c64-2439-4a34-8eb4-707e707c8ab1SPL set ID 89f262a4-a41b-41d7-806b-61b9b89542f0RxCUI 543786, 543789UNII 5NF5D4OPCI, U3RSY48JW5, EFW857872Q
Pharmacologic class: Ester Local Anesthetic; Standardized Chemical Allergen

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N410223020202 followed by a unit qualifier and the quantity

Package 10223-0202-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 10, 2025.

Indications (excerpt from the label)

Indications Cetacaine is a topical anesthetic indicated for the production of anesthesia of all accessible mucous membrane except the eyes. Cetacaine Spray is indicated for use to control pain or gagging. Cetacaine in all forms is indicated to control pain and for use for surgical or endoscopic or other procedures in the ear, nose, mouth, pharynx, larynx, trachea, bronchi, and esophagus. It may also be used for vaginal or rectal procedures when feasible.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)